MAWLP
Medically Assisted Weight Loss Programme.
A structured, clinician-led programme combining assessment, monitoring and ongoing support — delivered by our GP and nursing team at Bellview Clinic.
Healthy weight management can often feel very difficult to achieve. Worldwide obesity more than tripled between 1975 and 2022. At Bellview Clinics, we understand that every individual's journey with weight is unique. Obesity is a complex, chronic medical condition influenced by a combination of genetic, hormonal, neurological, emotional, and environmental factors. It is not a failure of willpower.
Our Medically Assisted Weight Loss Programme (MAWLP) is designed not only to help you reach your goals but to empower you with the tools, support, and guidance to build a healthier and more balanced life. The programme is built around safe, evidence-based medical care — each patient receives an initial GP consultation, a personalised plan, and structured follow-up appointments to monitor progress and adjust treatment.
Our programme is suitable for adults seeking long-term, medically supported weight management. We focus on responsible care — outcomes vary, and your clinician will discuss what is realistic for you. The MAWLP is rooted in compassion, respect, and science — and we are here to work with you, free of judgement, every step of the way.
What's included
- Comprehensive medical assessment
- Personalised treatment plan
- Regular GP-led follow-up
- Lifestyle and behavioural support
- Patient portal for questionnaires and forms
- Coordinated record of care
New patients complete our registration form and tick 'enrol in MAWLP'. Existing patients can book a pre-screening consult directly, or request patient portal access. Fees are discussed at the pre-screening consultation.
Programme journey
A clinician-led pathway from screening through ongoing follow-up.
Step 1
Register as a patient
If you're not already a patient of the practice, complete our new patient registration form and tick 'enrol in MAWLP'. Existing patients can book directly, or request patient portal access and tick 'enrol in MAWLP'.
Step 2
Pre-screening consult
A short consult to confirm you meet the clinical indications for the medication. You'll receive a starter pack of information and questionnaires to complete — these can also be filled in through the patient portal.
Step 3
Consenting consult with GP
Your GP reviews your questionnaires and assessment, discusses treatment options, side effects, contraindications and red flags, and completes the consent form together with you.
Step 4
Regular follow-up
Structured follow-up reviews with the GP and/or nurse to monitor progress and tolerance, screen for side effects, adjust dose, and order or review bloods where applicable. MAWLP is not covered by the GMS (Medical card).
Consultation schedule & fees
Transparent pricing across each stage of the programme.
Screening visit
€35
15 min consult with nurse
Disseminate lifestyle audit material, screen if you qualify for the Saxenda reimbursement programme and/or private GLP-1 prescription, and ensure bloods are in date.
Consenting & prescribing consult
€120
30 min with nurse + 15 min with doctor
Decide which medication will work best, agree a lifestyle-focused plan, discuss side effects, contraindications, administration technique, red flags, contraception (where applicable) and complete the consent form.
Follow-up visits
€70 / consult
15 min with doctor and/or nurse
Review progress and medication tolerance, screen for side effects and complications, adjust dose as needed, and order/review bloods where applicable.
Schedule — Ozempic / Wegovy / Mounjaro
- Month 1 — GP
- Month 2 — nurse + bloods
- Month 3 — GP
- Month 6 — GP
- Month 9 — nurse + bloods
- Month 12 — GP
- Bi-annually thereafter
Who qualifies
Eligibility is confirmed at your screening visit and is based on your BMI, bloods and blood pressure — not on your preference alone.
PCRS Saxenda reimbursement
- BMI over 35, and
- HbA1c 42–47 mmol/mol, and
- Elevated blood pressure or blood lipids
Private GLP-1 pathway
- BMI over 30, or
- BMI over 27 with elevated blood pressure, HbA1c or blood lipids
These thresholds reflect current PCRS and prescribing guidance and may be updated by your clinician as guidance changes.